Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression
Emma Hansson(Uppsala University), Lena E. Friberg(Uppsala University), Johan Wallin(Loxo Oncology at Lilly (United States)), Marie Sandström(Uppsala University Hospital), Henrik Lindman(Uppsala University), Mats O. Karlsson(Uppsala University)
Cited by 22
Related Papers
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
|The Lancet|2023|508
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
|PLoS ONE|2009|504
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
|The Lancet|2021|456